Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Thor R. Halfdanarson
Observed name:
Thor R. Halfdanarson, MD
Institution:
Mayo Clinic
Observed institutions:
Mayo Clinic,
Mayo Clinic Comprehensive Cancer Center (Minnesota)
OpenAlex ID:
A5111357674
Alpelisib and Immunotherapy: A Promising Combination for Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
2024
·
Riham Suleiman
, Patrick McGarrah
, et al.
·
Cancer Reports
·
6
PDF
Preliminary results from a Genome-Wide Association Study of pancreatic neuroendocrine neoplasms identify novel susceptibility loci
2025
·
Manuel Gentiluomo
, Laufey T. Amundadottir
, et al.
·
Pancreatology
S3517 Pancreatic Enzyme Therapy Nonadherence in a NET Patient: A GI Cause of Renal Injury
2025
·
Fares Jamal
, Jason S. Starr
, et al.
·
The American Journal of Gastroenterology
S3032 Use of Bile Acid Malabsorption Panel or Single Serum 7αC4 and Single Stool Primary Bile Acid Content in Patients With Treated Neuroendocrine Tumors
2025
·
Ayah Matar
, Thor R. Halfdanarson
, et al.
·
The American Journal of Gastroenterology
Rare germline variants in MEN1, TSC1, ATM, and MSH2 are associated with higher risk of pancreatic neuroendocrine tumors
2025
·
Samuel O. Antwi, PhD
, Kari G. Rabe, MS
, et al.
·
Endocrine Abstracts
Show more works
View as search
Works count:
5
Citation count:
6
H-index:
1
I10-index:
Year
Topic
Type
